DS Healthcare Group Announces Financial Results for Year Ended December 31, 2012

DS Healthcare Group Announces Financial Results for Year Ended December 31,
2012

Pompano Beach, April 25, 2013 (GLOBE NEWSWIRE) -- DS Healthcare Group, Inc.
(NASDAQ: DSKX), a leading developer of hair care, facial care and other
personal care products, announced today its Annual Report for 2012. Total net
revenues increased $1,551,562, or 16%, from $9,672,861 for the year ended
December 31, 2011 to $11,224,424 for the year ended December 31, 2012. Such
expansion also resulted in an increase in operating expenses. While the
company's net loss increased to a $3,623,110 net loss for the year ended
December 31, 2012, the company anticipates recognizing revenues of
approximately $2,000,000 of product orders during December 2012 that it was
unable to fulfill prior to December 31, 2012. These product orders were
subsequently shipped during the three months ended March 31, 2013.

The Company's chief executive officer, Daniel Khesin, stated, "2012 was a
tremendous year for DS Healthcare. We launched new products, expanded into new
markets, while increasing our presence in existing ones, commenced quotation
on NASDAQ and completed our first acquisition. Our continued growth and
expansion, while resulting in an increased net loss for the year, marked
another record year of revenues. While our operational expenses increased, we
believe such expenses have expedited our continued growth and expansion and we
look forward to continued growth in 2013."

On April 18, 2013, the Company received a notice from NASDAQ indicating that
the Company was not in compliance with one of NASDAQ's continued listing
standards due to the delinquent filing of its annual report on Form 10-K for
the year ended December 31, 2012 as set forth in NASDAQ Listing Rule
5250(c)(i). Upon filing of its annual report on April 24, 2013, the Company
regained compliance with NASDAQ continued listing standards.

About DS Healthcare Group

DS Healthcare Group, Inc. is a leading developer of hair care, facial care and
other personal care products. It markets through online and specialty
retailers, distributors, cosmetics wholesalers and salons. Its brands include
DS Laboratories (www.DSLaboratories.com), Sigma Skin (www.SigmaSkin.com),
Polaris Research Laboratories (www.PolarisReserachLabs.com) and Pure Guild
(www.ThePureGuild.com).

Forward-Looking Statements

Certain statements in this document and elsewhere by DS Healthcare Group are
"forward-looking statements" within the meaning of the Private Securities
Litigation Reform Act of 1995. Such information includes, without limitation,
the business outlook, assessment of market conditions, anticipated financial
and operating results, strategies, future plans, contingencies and
contemplated transactions of the Company. Such forward-looking statements are
not guarantees of future performance and are subject to known and unknown
risks, uncertainties and other factors which may cause or contribute to actual
results of company operations, or the performance or achievements of the
company or industry results, to differ materially from those expressed, or
implied by the forward-looking statements. DS Healthcare Group undertakes no
obligation to publicly update any forward-looking statements, whether as a
result of new information, future events or otherwise. Actual results,
performance or achievements could differ materially from those anticipated in
such forward-looking statements as a result of certain factors, including
those set forth in DS Healthcare Group's filings with the Securities and
Exchange Commission.

CONTACT: Contact:
        
         Laurel Moody
         Corporate Profile
         646 810 0608
 
Press spacebar to pause and continue. Press esc to stop.